Blood Advances发表Cellworks前瞻性基因组生物模拟研究，预测癌症治疗反应的准确率达到90%
September 19, 2019 12:13 ET
|
Cellworks Group, Inc.
旧金山, Sept. 20, 2019 (GLOBE NEWSWIRE) -- 精密医学领先机构及肿瘤治疗应答指数检测（TRI）技术的全球先锋企业 Cellworks 集团今天宣布：美国血液学会（ASH）期刊《Blood Advances》刊登了 iCare...
Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
September 19, 2019 12:13 ET
|
Cellworks Group, Inc.
SAN FRANCISCO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that Blood...
Cellworks myCare™ Clinical Trial Transforms NGS Data into Personalized Cancer Therapy Actions
June 03, 2019 08:00 ET
|
Cellworks Group, Inc.
CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- 2019 ASCO Annual Meeting – Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today...
Cellworks Study Predicted Non-Response to Azacitidine in MDS Patients with 100% Accuracy using AI-Driven Biosimulation
December 02, 2018 21:00 ET
|
Cellworks Group, Inc.
SAN DIEGO, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that its AI-driven...
Cellworks AI-Driven Biosimulation Predicted Chemo-resistance in AML and MDS Patients with 90% Accuracy
December 02, 2018 21:00 ET
|
Cellworks Group, Inc.
SAN DIEGO, Dec. 02, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that results from...
UPDATE -- Cellworks to Present 10 Abstracts at 2018 American Society of Hematology Annual Meeting
November 19, 2018 10:41 ET
|
Cellworks Group, Inc.
SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that...
Cellworks to Present 10 Abstracts at 2019 American Society of Hematology Annual Meeting
November 19, 2018 10:00 ET
|
Cellworks Group, Inc.
SAN JOSE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a leader in Precision Medicine and a global pioneer of Therapy Response Index (TRI) technology, today announced that...
Former UnitedHealth Group Cancer Director Dr. Lee Newcomer Joins Cellworks Board of Directors
October 17, 2018 08:00 ET
|
Cellworks Group, Inc.
Leading Precision Medicine Company Adds to Prestigious Board of Directors, which includes Dr. David Lawrence, Dr. Allen Lichter and Dr. Bill Rutter SAN JOSE, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE)...
Dr. Allen Lichter Joins Cellworks Group Board of Directors
May 31, 2018 08:00 ET
|
Cellworks Group, Inc.
SAN JOSE, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- Cellworks Group, Inc., a world leader in the field of Precision Medicine, announced today that Dr. Allen Lichter, former CEO of ASCO (American...